---
title: "Concord Healthcare Calls April EGM to Approve 2026 Credit Line and Guarantees"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279617956.md"
description: "Concord Healthcare Group Co., Ltd. has announced an extraordinary general meeting on April 10, 2026, in Beijing to seek shareholder approval for a comprehensive credit line and related guarantees for 2026. This move aims to enhance financing flexibility to support the company's operations and growth initiatives. The latest analyst rating for Concord Healthcare (HK:2453) is a Sell, with a price target of HK$1.50. The company operates in the Chinese healthcare market and is listed in Hong Kong."
datetime: "2026-03-18T13:51:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279617956.md)
  - [en](https://longbridge.com/en/news/279617956.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279617956.md)
---

# Concord Healthcare Calls April EGM to Approve 2026 Credit Line and Guarantees

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Concord Healthcare Group Co., Ltd. Class H ( (HK:2453) ) has shared an announcement.

Concord Healthcare Group Co., Ltd., a Hong Kong-listed healthcare services provider incorporated in the PRC, has convened an extraordinary general meeting for its shareholders. The company serves the Chinese medical market and is governed by a board comprising executive, non-executive and independent non-executive directors.

The company has called an extraordinary general meeting in Beijing on April 10, 2026, to seek shareholder approval for applying for a comprehensive credit line from financial institutions and providing related guarantees for 2026. Shareholders of both H shares and domestic shares are informed of the record dates, proxy arrangements and poll procedures, signaling a move to secure financing flexibility that could support the group’s operations and future growth initiatives.

The most recent analyst rating on (HK:2453) stock is a Sell with a HK$1.50 price target. To see the full list of analyst forecasts on Concord Healthcare Group Co., Ltd. Class H stock, see the HK:2453 Stock Forecast page.

**More about Concord Healthcare Group Co., Ltd. Class H**

Concord Healthcare Group Co., Ltd. is a PRC-incorporated healthcare company listed in Hong Kong under stock code 2453. The group operates within the medical and healthcare services sector, serving patients and stakeholders in China through its network and related healthcare operations.

**Average Trading Volume:** 349,878

**Technical Sentiment Signal:** Sell

**Current Market Cap:** HK$1.1B

### Related Stocks

- [02453.HK](https://longbridge.com/en/quote/02453.HK.md)

## Related News & Research

- [Concord Healthcare Completes HK$68 Million Convertible Bond Issue Under General Mandate](https://longbridge.com/en/news/286260367.md)
- [Concord Healthcare to Raise HK$68 Million via Convertible Bonds for Debt Repayment and Working Capital](https://longbridge.com/en/news/285858181.md)
- [05:54 ETTermHub™ Launches New Managed FHIR Offering for SDOs](https://longbridge.com/en/news/287042225.md)
- [Obamacare Enrollment Expected To Drop By Nearly Five Million As Costs Surge](https://longbridge.com/en/news/287132684.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)